Abstract
Multiple Sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system, causing increased vulnerability to infections and disability among young adults. Ever since the coronavirus disease 2019 (COVID-19) outbreak, caused by severe acute respiratory syndrome coronavirus 2 infections, there have been concerns among people with MS (PwMS) about the potential interactions between various disease-modifying therapies and COVID-19. The COVID-19 in MS Global Data Sharing Initiative (GDSI) was initiated in 2020 to address these concerns. This paper focuses on the anonymisation and open-sourcing of a GDSI sub-dataset, comprising dat
Catalogue metadata
- Record ID
- AISLI-R-DBAD3EB2FB552DC70F98
- Type
- Datasets
- Source catalogue
- registry.opendata.aws
- Topic
- 生命科学与生物医学
- Use conditions
- Creative Commons Attribution 4.0 International Public License